53, p smaller than .01) predicted intentions to plan (adj.

R-2 = 0.66). Intentions to plan (beta = 0.16, p smaller than .05) and intentions to be active (beta = 0.25, p smaller than .05) predicted change in planning behaviour (R-change(2) = 0.03). Planning behaviour (beta = 0.27, p smaller than .05) predicted change in physical activity (R-change(2) = 0.07). Planning behaviour appears to have its own motivations distinct from those of physical activity. Future interventions should target planning behaviour along with its motivations and control beliefs to increase rates of planning. The theoretical underpinnings of the TPB are of value for understanding both planning SRT1720 in vivo behaviour and physical activity. (C) 2014 Elsevier Ltd. All rights reserved.”
“We have previously shown that in patients with peripheral ischemia serum concentration of vascular endothelial growth factor (VEGF) differs depending on the disease severity being the highest in subjects with critical leg ischemia (CLI), although no apparent neoangiogenic effect like collateral circulation was observed in their ischemic tissues. Therefore, the aim of present study was to assess the effective proangiogenic

activity of sera from patients with peripheral ischemia. It was demonstrated that endothelial cells (HUVEC) incubated in medium enriched with 5% of sera from critical leg ischemia patients demonstrated greater proliferative activity than cells PF-562271 incubated with serum from healthy controls (p < 0.001). Also, their ability to form new sprouts Cilengitide in vitro was significantly greater when cultured in medium enriched with serum from patients with CLI (1025.85 +/- 316.56) in comparison to serum of moderate leg ischemia (MOD) (371.96 +/- 47.07) (p < 0.001) or controls. Thus, in patients with severe ischemia, VEGF is not only present in serum in considerably higher concentration than in healthy controls, but also is biologically

active, able to evoke appropriate responses in tissues.”
“We have synthesized and investigated a new bipheny1-4,4′-bis(nitronyl nitroxide) radical with intermediately strong antiferromagnetic interactions. This organic biradical belongs to a family of materials that can be used as a building block for the design of new quantum magnets. For quantum magnetism, special attention has been paid to coupled S = 1/2 dimer compounds, which when placed in a magnetic field, can be used as model systems for interacting boson gases. Short contacts between the oxygen atoms of the nitronyl nitroxide units and the hydrogen atoms of the benzene rings stabilize a surprisingly planar geometry of the biphenyl spacer and are responsible for a small magnetic interdimer coupling. The strength of the antiferromagnetic intradimer coupling constant J/k(B) = 14.0 +/- 0.9 K, fitting the experimental SQUID-data using an isolated-dimer model.